Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
BJU International|November 15, 2008
The feasibility of establishing a programme of adjuvant autologous vaccination for renal cell carcinomaRobin J Prestwich, Karen J Scott, Joanne Brown, et al.
International Journal of Cancer|February 13, 2013
The abrogation of the HOXB7/PBX2 complex induces apoptosis in melanoma through the miR-221&222-c-FOS pathwayM Cristina Errico, Federica Felicetti, Lisabianca Bottero, et al.
Molecular Therapy Oncolytics|March 5, 2020
The PERK Inhibitor GSK2606414 Enhances Reovirus Infection in Head and Neck Squamous Cell Carcinoma via an ATF4-Dependent MechanismMartin McLaughlin, Malin Pedersen, Victoria Roulstone, et al.
Nature Communications|July 28, 2025
The oncolytic adenovirus Ad-TD-nsIL12 in primary or progressive pediatric IDH wild-type diffuse intrinsic pontine glioma results of two phase I clinical trialsXiao Qian, Weihai Ning, Jingjing Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
Enhanced in vitro and in vivo cytotoxicity of combined reovirus and radiotherapyKatie Twigger, Laura Vidal, Christine L White, et al.
Cancer Research|December 3, 2008
Inhibition of repair of radiation-induced DNA damage enhances gene expression from replication-defective adenoviral vectorsMohan Hingorani, Christine L White, Andrew Merron, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
Immune-mediated antitumor activity of reovirus is required for therapy and is independent of direct viral oncolysis and replicationRobin J Prestwich, Elizabeth J Ilett, Fiona Errington, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2018
Immune Biomarkers Predictive for Disease-Free Survival with Adjuvant Sunitinib in High-Risk Locoregional Renal Cell Carcinoma: From Randomized Phase III S-TRAC StudyDaniel J George, Jean-François Martini, Michael Staehler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2014
Phase II randomized study of figitumumab plus docetaxel and docetaxel alone with crossover for metastatic castration-resistant prostate cancerJohann S de Bono, Josep M Piulats, Hardev S Pandha, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2010
REO-10: a phase I study of intravenous reovirus and docetaxel in patients with advanced cancerCharles Comins, James Spicer, Andrew Protheroe, et al.
Pageof 7